Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

Trulieve Cannabis (TCNNF) Gains from Sales and Divestitures (2021 - 2023)

Trulieve Cannabis (TCNNF) has 3 years of Gains from Sales and Divestitures data on record, last reported at $2.9 million in Q2 2023.

  • For Q2 2023, Gains from Sales and Divestitures changed 0.0% year-over-year to $2.9 million; the TTM value through Jun 2023 reached $2.9 million, changed 0.0%, while the annual FY2022 figure was $2.9 million, 0.7% down from the prior year.
  • Gains from Sales and Divestitures reached $2.9 million in Q2 2023 per TCNNF's latest filing, roughly flat from $2.9 million in the prior quarter.
  • Across five years, Gains from Sales and Divestitures topped out at $2.9 million in Q4 2021 and bottomed at $24444.0 in Q1 2022.
  • Average Gains from Sales and Divestitures over 3 years is $2.2 million, with a median of $2.9 million recorded in 2022.
  • Peak YoY movement for Gains from Sales and Divestitures: plummeted 98.43% in 2022, then soared 11763.85% in 2023.
  • A 3-year view of Gains from Sales and Divestitures shows it stood at $2.9 million in 2021, then decreased by 0.7% to $2.9 million in 2022, then changed by 0.0% to $2.9 million in 2023.
  • Per Business Quant database, its latest 3 readings for Gains from Sales and Divestitures were $2.9 million in Q2 2023, $2.9 million in Q1 2023, and $2.9 million in Q4 2022.